Eden Radioisotopes advances $1.4B New Mexico isotope facility targeting half of global Mo-99 demand

Eden Radioisotopes is advancing a $1.4B medical isotope production facility in New Mexico, which could produce 50% of global Mo-99 demand and address U.S. supply chain vulnerabilities for nuclear medicine procedures.

• The facility would be North America's first purpose-built medical isotope reactor and processing plant.
• Over 40,000 U.S. procedures daily rely on medical isotopes; their short half-lives make supply fragile.
• NRC construction permit filed; if approved, commercial Mo-99 production could begin by 2030.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.